Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VRTX compared with GE: revenue, margins and what each company keeps, and the suppliers and customers both name
VRTX
Vertex Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
GE
General Electric Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
VRTX
Vertex Pharmaceuticals Inc
vs
GE
General Electric Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
VRTX
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±4.9%
▼
−4.05%
×0.82
Q2 FY26
±5.2%
▲
+1.70%
×0.33
Q1 FY26
±5.4%
▼
−1.28%
×0.24
Feb 13 '26
±6.0%
▲
+5.69%
×0.95
GE
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±4.8%
▼
−3.67%
×0.77
Q2 FY26
±4.6%
▼
−4.06%
×0.89
= implied
VRTX realized, solid
GE realized, hatched
One scale, both sides: full bar = 8%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.2%
▼
−5.56%
×1.33
Jan 22 '26
±4.1%
▼
−7.38%
×1.80
VRTX
Vertex Pharmaceuticals Inc
Change
547.31
▲
+0.89%
· post 547.09
Mkt cap
$138.7B
Revenue
$3.4B
Q3 FY26
Revenue
$12.0B
FY25
GE
General Electric Co
Change
323.44
▲
+2.77%
· post 323.18
Closed
Nov 6 '26
Mkt cap
$334.0B
Revenue
$14.1B
Q3 FY26
Revenue
$45.9B
FY25
vs
Compare
Closed
Nov 6 '26
VRTX
Vertex Pharmaceuticals Inc
vs
GE
General Electric Co
547.31
▲
+0.89%
post 547.09
Price
323.44
▲
+2.77%
post 323.18
$138.7B
Mkt cap
$334.0B
Q3 FY26
$3.4B
Revenue
$14.1B
Q3 FY26
FY25
$12.0B
Revenue
$45.9B
FY25
Change
Change
VRTX
547.31
▲
+0.89%
vs
GE
323.44
▲
+2.77%
Closed
Nov 6 '26